For the study, David Thanassi, PhD, chair of the molecular genetics and microbiology department at Stony Brook (N.Y.) University, and his colleagues used crypto-electron microscopy — an advanced imaging technique — to analyze pili on the surface of E. coli.
Researchers discovered a previously unidentified stage in the pilus’ formation process.
“This discovery provides us with new insights into the mechanism by which bacteria build these essential virulence structures leading to infection,” Dr. Thanassi told Futurity. “Our findings open the door to new therapies targeting bacterial pili, and related virulence factors, as an alternative to traditional antibiotics.”
More articles on clinical leadership and infection control:
Viewpoint: What physicians may miss in reading lab results
Nevada hospital breaks its record for flu shots given in a day
Sen. Amy Klobuchar calls on CDC to investigate rise in polio-like illnesses
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit